Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ACE2 polymorphisms impact COVID-19 severity in obese patients.

Scientific reports - 13 Dec 2022

Jalaleddine Nour, Bouzid Amal, Hachim Mahmood, Sharif-Askari Narjes Saheb, Mahboub Bassam, Senok Abiola, Halwani Rabih, Hamoudi Rifat A, Al Heialy Saba

Abstract excerpt

A strong association between obesity and COVID-19 complications and a lack of prognostic factors that explain the unpredictable severity among these patients still exist despite the various vaccination programs. The expression of angiotensin converting enzyme 2 (ACE2), the main receptor for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is enhanced in obese individuals. The occurrence of frequent...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiotensin-Converting Enzyme 2
Share to COVID-19

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to COVID-19 Clinical Research Studies

Share to Long-Term Effects of COVID-19

Share to Obesity

Share to Polymorphism, Single Nucleotide

Share to SARS-CoV-2

Share to SARS-CoV-2 and COVID-19 Research

Source

Open in PubMed Open full text

Identifiers

PMID: 36513710
DOI: 10.1038/s41598-022-26072-7
PMCID: PMC9748040

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ACE2 polymorphisms impact COVID-19 severity in obese patients.PMID 36513710Read ↗

ACE2 levels are altered in comorbidities linked to severe outcome in COVID-19Semantic proximity Read ↗

Impact of Obesity-Associated SARS-CoV-2 Mutations on COVID-19 Severity and Clinical Outcomes.Semantic proximity Read ↗

An Overview of Adipose Tissue ACE2 Modulation by Diet and Obesity. Potential Implications in COVID-19 Infection and SeveritySemantic proximity Read ↗

GWAS-Identified Loci are Associated with Obesity and Type 2 Diabetes Mellitus in Patients with Severe COVID-19.Semantic proximity Read ↗

ACE Gene Variants Rise the Risk of Severe COVID-19 in Patients With Hypertension, Dyslipidemia or Diabetes: A Spanish Pilot Study.Semantic proximity Read ↗

Regulation of angiotensin converting enzyme 2 (ACE2) in obesity: implications for COVID-19Semantic proximity Read ↗

Polymorphisms in ACE, ACE2, AGTR1 genes and severity of COVID-19 disease.Semantic proximity Read ↗

Obesity and its impact on COVID-19Semantic proximity Read ↗

An observed association between angiotensin-converting enzyme 2 polymorphisms and COVID-19 severity in ChinaSemantic proximity Read ↗

An Updated Review on the Role of Single Nucleotide Polymorphisms in COVID-19 Disease Severity: A Global Aspect.Semantic proximity Read ↗

The Impact of ACE2 Polymorphisms on COVID-19 Disease: Susceptibility, Severity, and TherapySemantic proximity Read ↗

Association of obesity and its genetic predisposition with the risk of severe COVID-19: Analysis of population-based cohort data.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.